AAAAAA
Results:
1-23
|
Results: 23
Authors:
Bierman, PJ
Citation: Pj. Bierman, Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma - The Picozzi et al article reviewed, ONCOLOGY-NY, 15(10), 2001, pp. 1311
Authors:
Demirkazik, A
Kessinger, A
Armitage, JO
Bierman, PJ
Lynch, J
Vose, J
Chan, W
Sharp, JG
Citation: A. Demirkazik et al., Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation, BONE MAR TR, 28(2), 2001, pp. 207-212
Authors:
Vose, JM
Bierman, PJ
Weisenburger, DD
Lynch, JC
Bociek, G
Chan, WC
Greiner, TC
Armitage, JO
Citation: Jm. Vose et al., Autologous hematopoietic stem cell transplantation for mantle cell lymphoma, BIOL BLOOD, 6(6), 2000, pp. 640-645
Authors:
Vose, JM
Colcher, D
Gobar, L
Bierman, PJ
Augustine, S
Tempero, M
Leichner, P
Lynch, JC
Goldenberg, D
Armitage, JO
Citation: Jm. Vose et al., Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma, LEUK LYMPH, 38(1-2), 2000, pp. 91-101
Authors:
Weisenburger, DD
Gascoyne, RD
Bierman, PJ
Shenkier, T
Horsman, DE
Lynch, JC
Chan, WC
Greiner, TC
Connors, JM
Vose, JM
Armitage, JO
Sanger, WG
Citation: Dd. Weisenburger et al., Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma, LEUK LYMPH, 36(5-6), 2000, pp. 513-523
Authors:
Bierman, PJ
Citation: Pj. Bierman, High-dose therapy for follicular lymphoma - The Freedman/Friedberg/Gribbenarticle reviewed, ONCOLOGY-NY, 14(3), 2000, pp. 331
Authors:
Weisenburger, DD
Vose, JM
Greiner, TC
Lynch, JC
Chan, WC
Bierman, PJ
Dave, BJ
Sanger, WG
Armitage, JO
Citation: Dd. Weisenburger et al., Mantle cell lymphoma, a clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group, AM J HEMAT, 64(3), 2000, pp. 190-196
Authors:
Singh, RK
Varney, ML
Ino, K
Vose, JM
Bierman, PJ
Talmadge, JE
Citation: Rk. Singh et al., Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients, EXP HEMATOL, 28(5), 2000, pp. 499-507
Authors:
Bierman, PJ
Citation: Pj. Bierman, Allogeneic bone marrow transplantation for lymphoma, BLOOD REV, 14(1), 2000, pp. 1-13
Authors:
Pavletic, ZS
Arrowsmith, ER
Bierman, PJ
Goodman, SA
Vose, JM
Tarantolo, SR
Stein, RS
Bociek, G
Greer, JP
Wu, CD
Kollath, JP
Weisenburger, DD
Kessinger, A
Wolff, SN
Armitage, JO
Bishop, MR
Citation: Zs. Pavletic et al., Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia, BONE MAR TR, 25(7), 2000, pp. 717-722
Authors:
Bishop, MR
Tarantolo, SR
Geller, RB
Lynch, JC
Bierman, PJ
Pavletic, ZS
Vose, JM
Kruse, S
Dix, SP
Morris, ME
Armitage, JO
Kessinger, A
Citation: Mr. Bishop et al., A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation, BLOOD, 96(1), 2000, pp. 80-85
Authors:
Gale, RP
Park, RE
Dubois, R
Bierman, PJ
Fisher, RI
Loh, KK
Peterson, BA
Phillips, GL
Portlock, CS
Rosenblum, D
Armitage, JO
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma (vol 32, pg 139, 1998), LEUK LYMPH, 34(5-6), 1999, pp. NIL_3-NIL_3
Authors:
Tezcan, H
Vose, JM
Bast, M
Bierman, PJ
Kessinger, A
Armitage, JO
Citation: H. Tezcan et al., Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska Lymphoma Study Group experience, LEUK LYMPH, 34(3-4), 1999, pp. 273-285
Authors:
Bierman, PJ
Citation: Pj. Bierman, High-dose therapy with stem-cell transplantation in the malignant lymphomas - The Winter article reviewed, ONCOLOGY-NY, 13(12), 1999, pp. 1653-1654
Authors:
Abou-Elella, AA
Weisenburger, DD
Vose, JM
Kollath, JP
Lynch, JC
Bast, MA
Bierman, PJ
Greiner, TC
Chan, WC
Armitage, JO
Citation: Aa. Abou-elella et al., Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43patients from the Nebraska Lymphoma Study Group, J CL ONCOL, 17(3), 1999, pp. 784-790
Authors:
Baker, KS
Gordon, BG
Gross, TG
Abromowitch, MA
Lyden, ER
Lynch, JC
Vose, JM
Armitage, JO
Coccia, PF
Bierman, PJ
Citation: Ks. Baker et al., Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents, J CL ONCOL, 17(3), 1999, pp. 825-831
Authors:
Lazarus, HM
Rowlings, PA
Zhang, MJ
Vose, JM
Armitage, JO
Bierman, PJ
Gajewski, JL
Gale, RP
Keating, A
Klein, JP
Miller, CB
Phillips, GL
Reece, DE
Sobocinski, KA
van Besien, K
Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry, J CL ONCOL, 17(2), 1999, pp. 534-545
Authors:
Ageitos, AG
Varney, ML
Bierman, PJ
Vose, JM
Warkentin, PI
Talmadge, JE
Citation: Ag. Ageitos et al., Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products, BONE MAR TR, 23(1), 1999, pp. 63-69
Authors:
Bierman, PJ
Cavalli, F
Armitage, JO
Citation: Pj. Bierman et al., Unusual syndromes in Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 327-334
Authors:
Armitage, JO
Goldstone, AH
Carella, AM
Schmitz, N
Phillips, GL
Bierman, PJ
Citation: Jo. Armitage et al., Role of bone marrow transplantation in Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 521-530
Authors:
Pavletic, ZS
Bierman, PJ
Armitage, JO
Citation: Zs. Pavletic et al., Dose response and dose escalation, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 281-298
Authors:
Gale, RP
Park, RE
Dubois, R
Bierman, PJ
Fisher, RI
Loh, KK
Peterson, BA
Phillips, GL
Portlock, CS
Rosenblum, D
Armitage, JO
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma, LEUK LYMPH, 32(1-2), 1998, pp. 139-147
Authors:
Brand, RE
DiBaise, JK
Quigley, EMM
Gobar, LS
Harmon, KS
Lynch, JC
Bierman, PJ
Bishop, MR
Tarantolo, SR
Citation: Re. Brand et al., Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation, LANCET, 352(9145), 1998, pp. 1985-1985
Risultati:
1-23
|